NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 48 filers reported holding NOVOCURE LTD in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $21,131,000 | +93.9% | 2,691,801 | +110.9% | 0.00% | +100.0% |
| Q3 2016 | $10,899,000 | -21.7% | 1,276,265 | +7.0% | 0.00% | -33.3% |
| Q2 2016 | $13,914,000 | +389.1% | 1,192,298 | +506.8% | 0.00% | +200.0% |
| Q1 2016 | $2,845,000 | -38.4% | 196,485 | -4.9% | 0.00% | 0.0% |
| Q4 2015 | $4,618,000 | – | 206,546 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |